medroxyprogesterone acetate has been researched along with Pleural Effusion, Malignant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, H; Kondo, S; Sekishita, Y; Shiono, T; Suzuki, O | 1 |
| Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F | 1 |
1 review(s) available for medroxyprogesterone acetate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant | 1995 |
1 other study(ies) available for medroxyprogesterone acetate and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Positive response to oral chemoendocrine combination therapy using 5"-deoxy-5-fluorouridine for locally advanced breast cancer with carcinomatous pleurisy: report of a case.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Therapy, Combination; Endocrine System; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Quality of Life; Tamoxifen | 2003 |